Advertisement

Topics

Latest Gastroenterology NewsRSS

13:40 EST 15th December 2018 | BioPortfolio

New #Cancer Drug Saves Teen's Life $LOXO https://www.nbcdfw.com/news/local/New-Cancer-Drug-Saves-Teens-Life-502818421.html …

New #Cancer Drug Saves Teen's Life $LOXO https://www.nbcdfw.com/news/local/New-Cancer-Drug-Saves-Teens-Life-502818421.html …

Lethal combination: Drug cocktail turns off the juice to cancer cells https://www.unibas.ch/en/News-Events/News/Uni-Research/Drug-cocktail-turns-off-the-juice-to-cancer-cells.html …

Lethal combination: Drug cocktail turns off the juice to cancer cells https://www.unibas.ch/en/News-Events/News/Uni-Research/Drug-cocktail-turns-off-the-juice-to-cancer-cells.html …

MKSAP: 82-year-old woman with Alzheimer’s disease

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. An 82-year-old woman is seen for follow-up evaluation of Alzheimer disease. Since her last visit 12 weeks ago, she has been taking rivastigmine, with a progressively titrated dosage. The patient’s only new symptoms are increasing insomnia, loss of appetite, and occasional […...

Chronic red meat consumption alters gut microbiota, raises heart disease risk.

It is known that saturated fat in red meat has long been linked to a raised risk of heart disease, and that TMAO (trimethylamine N-oxide), a gut microbiota-generated metabolite, is also linked to the pathogenesis of heart disease.  However, the link between chronic dietary patterns on TMAO production, metabolism, and renal excretion is still unclear.  Now, a study from researchers

Biosimilar Approved By FDA For Treating HER2-overexpressing Breast Cancer

The FDA has approved trastuzumab-pkrb (Herzuma, Celltrion) as a biosimilar to trastuzumab (Herceptin, Genentech) for the treatment of HER2-overexpressing breast cancer. 

Trastuzumab Biosimilar CT-P6 Shows Comparable Efficacy at 2-Year Follow-up

CT-P6, a proposed biosimilar to trastuzumab, exhibited long-term disease-free survival and overall survival similar to the reference product in the treatment of patients with HER2-positive early breast cancer.

T-DM1 May Provide Less-Toxic Option in Older HER2+ Breast Cancer Population

Akihiko Shimomura, MD, PhD, discusses the rationale for the phase III HERB TEA trial of elderly patients with HER2-positive breast cancer.

An Interventional Approach to Pancreatic Cancer | Steve's Story

Being diagnosed with advanced metastatic pancreatic cancer was a grim experience for Steve Price. But thanks to his doctors at Weill Cornell Medicine and NewYork-Presbyterian, state-of-the-art interventional radiology allowed him to receive chemotherapy immediately after biopsy, shrinking his tumors dramatically. 

Following Pivotal Trials, Questions Remain With Bevacizumab in Recurrent Ovarian Cancer

Valerie Sugiyama, MD, discusses the treatment of patients with recurrent ovarian cancer.

uBiome Receives Patent for Microbiome-Derived Diagnostics and Therapeutics for Immune-Microbial Dysfunction

The leader in microbial genomics was granted a patent for the method and system of microbiome-derived diagnostics and therapeutics. SAN FRANCISCO (PRWEB) December 14, 2018 uBiome, the leader in microbial genomics, announced the issue of patent number 9,703,929 entitled “Method and System for Microbiome-Derived Diagnostics and Therapeutics” by the US Patent and Trademark Office on July 11, 201...

Opinion: I have a genetic disease, and know firsthand how important it is to think about preventing this disease for my family's health. https://buff.ly/2UKp5jW 

Opinion: I have a genetic disease, and know firsthand how important it is to think about preventing this disease for my family's health. https://buff.ly/2UKp5jW 

BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to $ABBV After Receiving Clearance https://www.prnewswire.com/news-releases/bioarctic-outlicenses-its-alpha-synuclein-antibody-portfolio-for-parkinsons-disease-to-abbvie

BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to $ABBV After Receiving Clearance https://www.prnewswire.com/news-releases/bioarctic-outlicenses-its-alpha-synuclein-antibody-portfolio-for-parkinsons-disease-to-abbvie-after-receiving-clearance-300765626.html …

Opinion: Genetic testing plus IVF can sidestep genetic disease and reduce the need for high-priced therapies

I have a genetic disease, and know firsthand how important it is to think about preventing this disease for my family's health.

Astellas Brings Light to the Lives of Cancer Patients

SOURCE: Astellas DESCRIPTION:At Astellas, we are dedicated to supporting and improving the lives of those impacted by cancer. One of the ways we provide this support is by working with patient advocacy organizations, such as The Leukemia and Lymphoma Society (LLS) – the world's largest voluntary health agency dedicated to blood cancers, including leukemia, lymphoma, Hodgkin's disease and myeloma...

Transitional Cell Cancer Urothelial Cell Cancer Global Clinical Trials Review, H2, 2018 [Report Updated: 31082018] Prices from USD $2125

Transitional Cell Cancer Urothelial Cell Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Transitional Cell Cancer Urothelial Cell Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Transitional Cell Cancer Urothelial Cell Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Transitional ...

Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease

The aim of this study was to identify fibrosis-related serological surrogate outcome measures in patients with immunoglobulin G4-related disease (IgG4-RD).

Is a Healthy Diet and Exercise Important for Delaying Progression of PD?

The progression of Parkinson disease and response to medication varies widely across individuals, which can make the prediction of disease course challenging.

Targeting PI3K Remains Complex in Cancer Therapy

Dr. Lewis Cantley discusses targeting the PI3K pathway in breast cancer and the importance of managing ambient insulin levels during therapy.

Exercise Significantly Cuts the Risk of Death from Cancer, Roswell Park Study Shows

New research out of Roswell Park Comprehensive Cancer Center shows that cancer patients who exercise regularly both before and after their diagnosis are significantly more likely to survive than those who are sedentary, adding to the growing body of evidence that physical activity is an important part of a cancer prevention and treatment strategy. BUFFALO, N.Y. (PRWEB) December 13, 2018 New resea...

Childbirth increases a woman’s breast cancer risk

Women are at an increased risk for breast cancer for more than 20 years after giving birth, according to a new study published in the Annals of Internal Medicine. This, the authors noted, means that a recent childbirth should be viewed as a risk factor for young women.

Texas 21 coalition seeks to increase smoking age to prevent cancer

The Texas 21 coalition—a partnership among several healthcare organizations across Texas—is advocating to increase the smoking age from 18 to 21 across the state, according to a new report published in the Longview News-Journal. Raising the age, the coalition believes, will reduce the financial burdens of treating lung cancer and other diseases.

UK’s NICE recommends non-invasive MRI scan for prostate cancer

NICE stated that mpMRI creates detailed images of the prostate gland to allowclinicians to better identify suspected prostate cancer. Presently, blood test is conducted for men with suspected The post UK’s NICE recommends non-invasive MRI scan for prostate cancer appeared first on Compelo Medical Devices.

EU Panel Backs Maintenance Rucaparib for Ovarian Cancer

The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended to expand the approval of single-agent rucaparib as a maintenance therapy in adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.

Pulmonologist Highlights Latest Diagnostic and Staging Techniques in Lung Cancer

Manju P. Paul, MD, discusses new diagnostic and staging techniques that are advancing standards of care in patients with lung cancer.

BRCA Focus in Ovarian Cancer Turns to Preventive Testing for Inherited Mutations

The frequency of hereditary mutations that convey an increased risk of ovarian cancer suggests that many cases of the disease are preventable.

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Gastroenterology market research data and corporate reports here